glp-1 weight loss drug news today Retatrutide for loss: Study shows 30% body weight Social media data helps AI
Description
At 10 years, the survival probability was 96.9% for GLP-1RA use and 76.4% for insulin/metformin use
The First Wave: Older GLP-1 Medications Before semaglutide stole the spotlight, several other GLP-1 agonists were used primarily for diabetes management, with modest weight loss benefits
Early clinical phase 1 data has provided mixed results on body weight, with some compounds failing to outperform GLP-1R agonists 83 , while others have shown greater efficacy 84
Mechanisms of weight regain
Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function
Every Innovative Vitality patient is prescribed a blood sugar monitor to wear for a period of time
